J Med Genet

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McNeil, D E
Right arrow Articles by Glenn, G M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNeil, D E
Right arrow Articles by Glenn, G M
Journal of Medical Genetics 2002;39:e37-e37
© 2002 Journal of Medical Genetics


ELECTRONIC LETTER

Comorbid VHL and SCA2 mutations in a large kindred: confounding diagnosis of neurological dysfunction caused by CNS VHL vascular tumours versus SCA2 atrophic neurodegeneration

D E McNeil1, W M Linehan2, G M Glenn1

1 Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
2 Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Correspondence to:
Dr G M Glenn, Division of Cancer Epidemiology and Genetics, NCI/NIH/EPS/Room 7108, 6120 Executive Boulevard, MSC 7236, Bethesda, MD 20892-7236, USA;
glenng@nih.gov]

Keywords: von Hippel-Lindau disease; spinocerebellar ataxia type 2; CNS dysfunction

Abbreviations: VHL, von Hippel-Lindau disease; SCA2, spinocerebellar ataxia type 2; OPCA, olivopontocerebellar atrophy; HIF, hypoxia inducible factor; VEGF, vascular endothelial growth factor

The first 150 words of the full text of this article appear below.

Von Hippel-Lindau disease (VHL, MIM 193300) is an autosomal dominant heritable neoplastic disorder resulting from any one of 1631 or more non-polymorphic mutations2 found in the VHL tumour suppressor gene on chromosome 3p25.3 Inheritance of a mutated VHL gene predisposes to development of specific types of tumours, including brain and spinal cord haemangioblastoma, renal clear cell carcinoma, phaeochromocytoma, retinal angioma, pancreatic neuroendocrine tumour/islet cell carcinoma, endolymphatic sac tumour, and epididymal and broad ligament papillary cystadenoma.4–8

The spinocerebellar ataxias, also referred to as olivopontocerebellar atrophy, are a diverse group of neurodegenerative disorders associated with atrophy and dysfunction of the cerebellum and brain stem. Varying degrees of extracerebellar manifestations including neuropathy and oculomotor disorders, such as slow saccades and/or ophthalmoplegia, have been described.9

We present clinical and genetic findings for members of a large kindred with a history of both von Hippel-Lindau disease (VHL) and spinocerebellar ataxia type 2 (SCA2, MIM 183090). . . . [Full text of this article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 by the BMJ Publishing Group Ltd.